WE‐C‐224C‐05: Tumor Brachytherapy Using Intratumoral Injection of Beta‐Emitting Therapeutic Radionuclides Carried Within Nanoparticles

A. Bao, William T Phillips, B. Goins, Randal A Otto

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The use of beta‐emitting therapeutic radionuclides carried within nanoparticles for brachytherapy potentially offers significantl advantages over sealed sources. By using an active trapping technique, both therapeutic radionuclides, 186Re and 188Re, and diagnostic radionuclides, 99mTc, can be encapsulated in liposomes with high efficiency and high specific activity. 186Re and 188Re are beta emitters with appropriate ratio and energies of gamma emission which enable the imaging of in vivo distribution with a clinical gamma camera. The 90% absorbed dose deposit distances in soft tissue of beta ray from 186Re and 188Re are 1.8 mm and 4.2 mm respectively. To study the potential of using therapeutic radionuclides carried within liposomes for tumor brachytherapy, the intratumoral distribution and retention of 99mTc‐liposomes in head and neck squamous cell carcinoma xenografts in nude rats were determined using imaging with a dedicated dual modality animal micro‐SPECT / CT scanner. Using an intratumoral administration technique developed in our lab, the volume of administered radioactivity up to over 40 % of tumor volume can be delivered to tumor with a high local retention. The 99mTc‐liposome studies show that about 40 % of injected activity remained in tumor with a very slow clearance. The cleared activity was not retained in the nearby critical organ. Using pin‐hole collimators with a spatial resolution of 1 mm, the 99mTc‐activity had a broad diffusion throughout the tumor even though the injection was at one point within the tumor. This study has shown the potential of using beta‐emitting therapeutic radionuclides carried within nanoparticles for tumor brachytherapy. The high intratumoral retention enables a high intratumoral radiation absorbed dose, while the penetration of beta‐particles within only a few mm decreases the toxicity to nearby critical organs, and the intratumoral diffusion makes the intratumoral administration simpler and provides for a better intratumoral absorbed dose homogeneity.

Original languageEnglish (US)
Pages (from-to)2236-2237
Number of pages2
JournalMedical Physics
Volume33
Issue number6
DOIs
StatePublished - 2006

Fingerprint

Brachytherapy
Radioisotopes
Nanoparticles
Injections
Neoplasms
Liposomes
Therapeutics
Beta Particles
Nude Rats
Gamma Cameras
Therapeutic Uses
Tumor Burden
Heterografts
Radioactivity
Radiation

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

WE‐C‐224C‐05 : Tumor Brachytherapy Using Intratumoral Injection of Beta‐Emitting Therapeutic Radionuclides Carried Within Nanoparticles. / Bao, A.; Phillips, William T; Goins, B.; Otto, Randal A.

In: Medical Physics, Vol. 33, No. 6, 2006, p. 2236-2237.

Research output: Contribution to journalArticle

@article{477a89d7033f4f9b9290ed4d7ba97ffe,
title = "WE‐C‐224C‐05: Tumor Brachytherapy Using Intratumoral Injection of Beta‐Emitting Therapeutic Radionuclides Carried Within Nanoparticles",
abstract = "The use of beta‐emitting therapeutic radionuclides carried within nanoparticles for brachytherapy potentially offers significantl advantages over sealed sources. By using an active trapping technique, both therapeutic radionuclides, 186Re and 188Re, and diagnostic radionuclides, 99mTc, can be encapsulated in liposomes with high efficiency and high specific activity. 186Re and 188Re are beta emitters with appropriate ratio and energies of gamma emission which enable the imaging of in vivo distribution with a clinical gamma camera. The 90{\%} absorbed dose deposit distances in soft tissue of beta ray from 186Re and 188Re are 1.8 mm and 4.2 mm respectively. To study the potential of using therapeutic radionuclides carried within liposomes for tumor brachytherapy, the intratumoral distribution and retention of 99mTc‐liposomes in head and neck squamous cell carcinoma xenografts in nude rats were determined using imaging with a dedicated dual modality animal micro‐SPECT / CT scanner. Using an intratumoral administration technique developed in our lab, the volume of administered radioactivity up to over 40 {\%} of tumor volume can be delivered to tumor with a high local retention. The 99mTc‐liposome studies show that about 40 {\%} of injected activity remained in tumor with a very slow clearance. The cleared activity was not retained in the nearby critical organ. Using pin‐hole collimators with a spatial resolution of 1 mm, the 99mTc‐activity had a broad diffusion throughout the tumor even though the injection was at one point within the tumor. This study has shown the potential of using beta‐emitting therapeutic radionuclides carried within nanoparticles for tumor brachytherapy. The high intratumoral retention enables a high intratumoral radiation absorbed dose, while the penetration of beta‐particles within only a few mm decreases the toxicity to nearby critical organs, and the intratumoral diffusion makes the intratumoral administration simpler and provides for a better intratumoral absorbed dose homogeneity.",
author = "A. Bao and Phillips, {William T} and B. Goins and Otto, {Randal A}",
year = "2006",
doi = "10.1118/1.2241710",
language = "English (US)",
volume = "33",
pages = "2236--2237",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - WE‐C‐224C‐05

T2 - Tumor Brachytherapy Using Intratumoral Injection of Beta‐Emitting Therapeutic Radionuclides Carried Within Nanoparticles

AU - Bao, A.

AU - Phillips, William T

AU - Goins, B.

AU - Otto, Randal A

PY - 2006

Y1 - 2006

N2 - The use of beta‐emitting therapeutic radionuclides carried within nanoparticles for brachytherapy potentially offers significantl advantages over sealed sources. By using an active trapping technique, both therapeutic radionuclides, 186Re and 188Re, and diagnostic radionuclides, 99mTc, can be encapsulated in liposomes with high efficiency and high specific activity. 186Re and 188Re are beta emitters with appropriate ratio and energies of gamma emission which enable the imaging of in vivo distribution with a clinical gamma camera. The 90% absorbed dose deposit distances in soft tissue of beta ray from 186Re and 188Re are 1.8 mm and 4.2 mm respectively. To study the potential of using therapeutic radionuclides carried within liposomes for tumor brachytherapy, the intratumoral distribution and retention of 99mTc‐liposomes in head and neck squamous cell carcinoma xenografts in nude rats were determined using imaging with a dedicated dual modality animal micro‐SPECT / CT scanner. Using an intratumoral administration technique developed in our lab, the volume of administered radioactivity up to over 40 % of tumor volume can be delivered to tumor with a high local retention. The 99mTc‐liposome studies show that about 40 % of injected activity remained in tumor with a very slow clearance. The cleared activity was not retained in the nearby critical organ. Using pin‐hole collimators with a spatial resolution of 1 mm, the 99mTc‐activity had a broad diffusion throughout the tumor even though the injection was at one point within the tumor. This study has shown the potential of using beta‐emitting therapeutic radionuclides carried within nanoparticles for tumor brachytherapy. The high intratumoral retention enables a high intratumoral radiation absorbed dose, while the penetration of beta‐particles within only a few mm decreases the toxicity to nearby critical organs, and the intratumoral diffusion makes the intratumoral administration simpler and provides for a better intratumoral absorbed dose homogeneity.

AB - The use of beta‐emitting therapeutic radionuclides carried within nanoparticles for brachytherapy potentially offers significantl advantages over sealed sources. By using an active trapping technique, both therapeutic radionuclides, 186Re and 188Re, and diagnostic radionuclides, 99mTc, can be encapsulated in liposomes with high efficiency and high specific activity. 186Re and 188Re are beta emitters with appropriate ratio and energies of gamma emission which enable the imaging of in vivo distribution with a clinical gamma camera. The 90% absorbed dose deposit distances in soft tissue of beta ray from 186Re and 188Re are 1.8 mm and 4.2 mm respectively. To study the potential of using therapeutic radionuclides carried within liposomes for tumor brachytherapy, the intratumoral distribution and retention of 99mTc‐liposomes in head and neck squamous cell carcinoma xenografts in nude rats were determined using imaging with a dedicated dual modality animal micro‐SPECT / CT scanner. Using an intratumoral administration technique developed in our lab, the volume of administered radioactivity up to over 40 % of tumor volume can be delivered to tumor with a high local retention. The 99mTc‐liposome studies show that about 40 % of injected activity remained in tumor with a very slow clearance. The cleared activity was not retained in the nearby critical organ. Using pin‐hole collimators with a spatial resolution of 1 mm, the 99mTc‐activity had a broad diffusion throughout the tumor even though the injection was at one point within the tumor. This study has shown the potential of using beta‐emitting therapeutic radionuclides carried within nanoparticles for tumor brachytherapy. The high intratumoral retention enables a high intratumoral radiation absorbed dose, while the penetration of beta‐particles within only a few mm decreases the toxicity to nearby critical organs, and the intratumoral diffusion makes the intratumoral administration simpler and provides for a better intratumoral absorbed dose homogeneity.

UR - http://www.scopus.com/inward/record.url?scp=84887190987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887190987&partnerID=8YFLogxK

U2 - 10.1118/1.2241710

DO - 10.1118/1.2241710

M3 - Article

AN - SCOPUS:84887190987

VL - 33

SP - 2236

EP - 2237

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -